Top Industry Leaders in the Prils Market
Latest Prils Companies Update
-
September 2023: A novel generic medication introduced by Pharmascience Canada for the treatment of hypertension. Adults are initially prescribed pms-PERINDOPRIL-INDAPAMIDE (perindopril erbumine/indapamide) to treat essential hypertension ranging from mild to moderate. The PMS-PERINDOPRIL-INDAPAMIDE (perindopril erbumine/indapamide) comprises the angiotensin converting enzyme (ACE) inhibitor perindopril erbumine and the chlorosulfamoyl diuretic indapamide. These two active constituents reduce blood pressure in hypertensive patients of all ages through a synergistic effect. The Pharmascience team is delighted to introduce pms-Perindopril-Indapamide, which is intended for the initial management of hypertension. The accessibility of PMS-Perindopril-Indapamide provides an essential and cost-effective treatment alternative for all Canadian citizens.
-
January 2023: Amazon unveiled a novel prescription drug program that offers subscribers an unlimited number of medications for a fixed fee. This development represents the online retailer's most recent effort to entice customers away from traditional drugstores as major technology companies expand their presence in the healthcare industry. The online retailer RxPass will enable U.S. Prime members to complete an unlimited number of prescriptions for generic medications from a list of over 50 and receive free delivery. Antibiotics amoxicillin and doxycycline, antifungal nystatin, blood pressure medication losartan lisinopril, ramipril, and anti-inflammatory naproxen are included on the list of covered medications. A series of generic medications used to treat mental health disorders such as schizophrenia, bipolar disorder, depression, and anxiety are also included. In addition to broadening its presence in primary care, mental health, and telehealth, the organization is negotiating a nearly $4 billion acquisition of healthcare provider One Medical.
List of Prils Key companies in the market
- Mylan N.V. (U.S.)
- MERCK KGaA, (Germany)
- Lupin (India)
- Aurobindo Pharma (India)
- Pfizer (U.S.)
- Sun Pharmaceuticals (India)
- Novartis (Switzerland)
- Canadian Pharmaceuticals (Canada)
- Manus Aktteva Biopharma LLP (India)
- Hoffman La Roche (Switzerland)
- Boehringer Ingelheim International Gmbh (Germany)
- Teva Pharmaceutical Industries (U.S.)